Health
FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer – News-Medical.Net
The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss…
Reviewed by Emily Henderson, B.Sc.Nov 23 2020
The U.S. Food and Drug Administration has request for emergency use authorization a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH.
The FDA recognizes that transparency and dialogue are critical for the public to have confidence in COVID-19 vaccines. I want…
-
General19 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General20 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
Business23 hours agoWhat $10,000 invested in the iShares S&P 500 IVV ETF could be in 10 years
-
Noosa News21 hours agoTeenager airlifted to hospital after shark bites his stomach on Thursday Island in Far North Queensland